Then, when we analyzed hepatic relative mRNA expression of SFRP5 according to different degrees of NAFLD, we found that SFRP5 expression was significantly higher in patients with SS than those with NL or NASH. The gene discussed is SFRP5; the disease is metabolic dysfunction-associated steatotic liver disease.